Cancer Institute A national cancer institute
designated cancer center

Benjamin I. Chung

Publication Details

  • Cost-effectiveness analysis of nephron sparing options for the management of small renal masses.

    Chang SL, Cipriano LE, Harshman LC, Garber AM, Chung BI. J Urol. 2011; 185 (5): 1591-7

    A recent increase in the detection of contrast enhancing renal masses 4 cm or smaller suspicious for malignancy has led to the widespread use of nephron sparing options. Limited data exist to help clinicians decide which of these competing nephron sparing therapies is most appropriate. We performed a cost-effectiveness analysis to evaluate the relative clinical and economic merits of commonly available nephron sparing strategies for small renal masses.

    PubMedID: 21419445

Stanford Medicine Resources:

Footer Links: